INMODE LTD (INMD) Stock Price, Quote, News and Overview
NASDAQ:INMD - Nasdaq - IL0011595993 - Common Stock - Currency: USD
INMD Quote, Performance and Key Statistics
14.3
+0.05 (+0.35%)
The current stock price of INMD is 14.3 USD. In the past month the price decreased by -7.14%. In the past year, price decreased by -20.99%.
INMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.84 | 230.77B | ||
| ISRG | INTUITIVE SURGICAL INC | 69.43 | 190.13B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.56 | 154.00B | ||
| SYK | STRYKER CORP | 30.13 | 144.10B | ||
| MDT | MEDTRONIC PLC | 15.42 | 105.58B | ||
| BDX | BECTON DICKINSON AND CO | 11.72 | 47.42B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.82 | 44.05B | ||
| IDXX | IDEXX LABORATORIES INC | 41.55 | 38.39B | ||
| RMD | RESMED INC | 26.65 | 35.48B | ||
| DXCM | DEXCOM INC | 49.41 | 31.97B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.58 | 30.72B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.34 | 22.64B |
Related stock screener links
About INMD
Company Profile
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Company Info
INMODE LTD
Tavor Building, Sha'ar Yokneam, Pob 533
Yokneam 2069200 IL
CEO: Moshe Mizrahy
Employees: 599
Phone: 97249097470
INMODE LTD / INMD FAQ
What is the stock price of INMODE LTD today?
The current stock price of INMD is 14.3 USD. The price increased by 0.35% in the last trading session.
What is the ticker symbol for INMODE LTD stock?
The exchange symbol of INMODE LTD is INMD and it is listed on the Nasdaq exchange.
On which exchange is INMD stock listed?
INMD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for INMODE LTD stock?
13 analysts have analysed INMD and the average price target is 21.59 USD. This implies a price increase of 50.98% is expected in the next year compared to the current price of 14.3. Check the INMODE LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INMODE LTD worth?
INMODE LTD (INMD) has a market capitalization of 970.54M USD. This makes INMD a Small Cap stock.
How many employees does INMODE LTD have?
INMODE LTD (INMD) currently has 599 employees.
What are the support and resistance levels for INMODE LTD (INMD) stock?
INMODE LTD (INMD) has a support level at 14.29 and a resistance level at 15.37. Check the full technical report for a detailed analysis of INMD support and resistance levels.
Is INMODE LTD (INMD) expected to grow?
The Revenue of INMODE LTD (INMD) is expected to decline by -2.71% in the next year. Check the estimates tab for more information on the INMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INMODE LTD (INMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of INMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of INMD, evaluating the profitability, health, valuation and growth aspects
- INMODE LTD (INMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INMODE LTD (INMD) Sales and EPS estimates to see what analysts future expectations are.
- INMODE LTD (INMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INMODE LTD (INMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- INMODE LTD (INMD) Stock Chart to make your own analysis
- INMODE LTD (INMD) Latest news and press-releases to stay up to date.
Does INMODE LTD (INMD) stock pay dividends?
INMD does not pay a dividend.
When does INMODE LTD (INMD) report earnings?
INMODE LTD (INMD) will report earnings on 2025-07-30, before the market open.
What is the Price/Earnings (PE) ratio of INMODE LTD (INMD)?
The PE ratio for INMODE LTD (INMD) is 8.08. This is based on the reported non-GAAP earnings per share of 1.77 and the current share price of 14.3 USD. Check the full fundamental report for a full analysis of the valuation metrics for INMD.
What is the Short Interest ratio of INMODE LTD (INMD) stock?
The outstanding short interest for INMODE LTD (INMD) is 11.17% of its float. Check the ownership tab for more information on the INMD short interest.
INMD Technical Analysis
INMD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to INMD. INMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
INMD Financial Highlights
Over the last trailing twelve months INMD reported a non-GAAP Earnings per Share(EPS) of 1.77. The EPS decreased by -25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 44.8% | ||
| ROA | 24.94% | ||
| ROE | 28.38% | ||
| Debt/Equity | 0 |
INMD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to INMD. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 10.39% and a revenue growth -2.71% for INMD